je.st
news
Upcoming Reslizumab PDUFA- Approval Odds, And What It Means For Teva
2016-02-22 20:11:31| Biotech - Topix.net
Come March and investors in Teva would keenly await the USFDA decision on its novel asthma biologic drug candidate reslizumab. Reslizumab PDUFA action date is in March 2016.
Tags: means
approval
upcoming
odds
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|